Related Experiment Video
Updated: May 31, 2026
07:14
Ookluc: A Plasmodium berghei Line for Identifying Transmission-blocking Compounds
Published on: July 11, 2025
Targeting Plasmodium liver stages: better late than never
Steffen Borrmann1, Kai Matuschewski
1Department of Infectious Diseases, Heidelberg University School of Medicine, 69120 Heidelberg, Germany. sborrmann@kilifi.kemri-wellcome.org
Trends in Molecular Medicine
|July 9, 2011
Summary
Eliminating malaria requires novel strategies beyond current interventions. Whole-parasite vaccines targeting the Plasmodium liver stage offer a promising approach to block parasite development and prevent disease.
Area of Science:
- Malariology
- Vaccinology
- Parasitology
Background:
- Malaria remains a significant global health burden, necessitating innovative control measures.
- Existing interventions reduce malaria but cannot achieve elimination.
- Novel vaccine strategies are crucial for Plasmodium eradication.
Purpose of the Study:
- To review whole-parasite vaccination strategies against the Plasmodium liver stage.
- To discuss the evidence, targets, and opportunities for these vaccine approaches.
- To explore methods for blocking parasite development from liver to blood stages.
Main Methods:
- Review of preclinical and clinical research on whole-parasite vaccines.
- Analysis of experimental attenuation strategies for Plasmodium.
- Examination of preventive drug administration during sporozoite transmission.
Main Results:
- Whole-parasite immunization strategies aim to block Plasmodium liver-stage development.
- Experimental attenuation and drug administration show potential for protective immunity.
- Focus on the liver stage bottleneck is key for blocking parasite conversion.
Conclusions:
- Whole-cell-based vaccination targeting the Plasmodium liver stage is a promising avenue for malaria elimination.
- Further preclinical and clinical research is needed to optimize these strategies.
- Blocking the transition from the silent liver phase to symptomatic blood-stage infection is critical.
Related Concept Videos
01:29Malaria
Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
01:21Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...
00:58Symbiosis
Symbiotic relationships are long-term, close interactions between individuals of different species that affect the distribution and abundance of those species. When a relationship is beneficial to both species, this is called mutualism. When the relationship is beneficial to one species but neither beneficial nor harmful to the other species, this is called commensalism. When one organism is harmed to benefit another, the relationship is known as parasitism. These types of relationships often...